Not available
Quote | HUTCHMED (China) Limited (NASDAQ:HCM)
Last: | $20.22 |
---|---|
Change Percent: | -3.64% |
Open: | $19.63 |
Close: | $20.22 |
High: | $20.34 |
Low: | $19.63 |
Volume: | 102,701 |
Last Trade Date Time: | 07/22/2024 03:00:00 am |
News | HUTCHMED (China) Limited (NASDAQ:HCM)
2024-07-05 13:41:36 ET More onHutchmed, Ipsen S.A., etc. Ipsen expands collaboration agreement with Exelixis Ipsen gains accelerated approval for elafibranor for rare liver disease Seeking Alpha’s Quant Rating on Hutchison China MediTech Historica...
2024-07-04 11:09:32 ET Summary CK Hutchison Holdings Ltd. trades at an inexpensive valuation both in terms of earnings multiples and relative to its sum of the parts valuation. The company's limited geographic exposure to Greater China makes a "China discount" unwarranted, in my o...
Message Board Posts | HUTCHMED (China) Limited (NASDAQ:HCM)
Subject | By | Source | When |
---|---|---|---|
The now last up | MWM | investorshub | 05/10/2023 3:35:25 PM |
$HCM Time for this to show some returns | MWM | investorshub | 05/08/2023 7:41:07 PM |
$HCM MomentumIts gaining | crowin | investorshub | 05/08/2023 7:12:07 AM |
short squeeze | MWM | investorshub | 05/08/2023 1:11:22 AM |
$HCM The trading last up | MWM | investorshub | 05/07/2023 6:33:31 AM |
News, Short Squeeze, Breakout and More Instantly...
HUTCHMED (China) Limited Company Name:
HCM Stock Symbol:
NASDAQ Market:
HUTCHMED (China) Limited Website:
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., July 04, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“ HUTCHMED ”) (Nasdaq/AIM:HCM; HKEX:13) today announces that the New Drug Application (“NDA”) for tazemetostat for the treatment of adult pati...
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., June 26, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“ HUTCHMED ”) (Nasdaq/AIM: HCM; SEHK:13) will be announcing its interim results for the six months ended June 30, 2024 on Wednesday, July 31, 2024 at 7:00 am Eastern Daylig...
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., June 24, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“ HUTCHMED ”) (Nasdaq/AIM:HCM; HKEX:13) today announces that it will host a R&D update in Shanghai, China, and via webcast on Tuesday, July 9, 2024. During t...